IGHV3-25: Unlocking The Potential of An Antibody Response Protein

Target Name: IGHV3-25

NCBI ID: G28441

IGHV3-25

Other Name(s): immunoglobulin heavy variable 3-25 (pseudogene) | IGHV325 | Immunoglobulin heavy variable 3-25 (pseudogene) | 3-25P

IGHV3-25: Unlocking The Potential of An Antibody Response Protein

IGHV3-25, also known as immunoglobulin heavy variable 3-25 (pseudogene), is a protein that is expressed in many tissues throughout the body. It is a member of the immunoglobulin family, which is a group of proteins that are responsible for the immune response. IGHV3-25 is one of the heavy chains of this family, which consists of four chains: alpha, beta, gamma, and delta.

IGHV3-25 is a glycoprotein that consists of 216 amino acids. It is expressed in many tissues, including the liver, spleen, kidney, and heart. It is also found in the blood and lymph fluid.

One of the key functions of IGHV3-25 is its role in the immune response. It is a component of the antibody response, which is the process by which the immune system protects the body against infection and disease. IGHV3-25 is part of the heavy chain of antibodies, which is responsible for binding to foreign substances in the body and triggering an immune response.

IGHV3-25 has also been shown to play a role in regulation of inflammation. It is involved in the regulation of the production and function of other immune cells, such as T cells and B cells. It is also involved in the regulation of the production of antibodies, which is a critical part of the immune response.

Another function of IGHV3-25 is its role in cancer. It has been shown to be involved in the development and progression of many types of cancer, including blood cancers and solid tumors. It is also involved in the regulation of cell signaling, which is important for the growth and survival of cancer cells.

IGHV3-25 is also a potential drug target. Researchers are studying its potential as a therapeutic agent for a variety of conditions, including cancer, autoimmune diseases, and infections. One of the main reasons for its potential as a drug is its ability to interact with several different signaling pathways, which can lead to a wide range of potential therapeutic effects.

In addition to its potential therapeutic uses, IGHV3-25 is also of interest as a biomarker. Its expression has been shown to be affected by a number of different factors, including disease status, drug treatment, and other environmental factors. This makes it a potential source of information about disease status and response to therapy.

Overall, IGHV3-25 is a protein that is expressed in many tissues throughout the body and is involved in the immune response and regulation of inflammation. Its potential as a drug target and biomarker makes it an important area of research. Further studies are needed to fully understand its role in disease and its potential as a therapeutic agent.

Protein Name: Immunoglobulin Heavy Variable 3-25 (pseudogene)

The "IGHV3-25 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHV3-25 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets